{"id":"https://openalex.org/W1997378488","doi":"https://doi.org/10.1111/j.1600-0447.1990.tb05317.x","title":"Some basic aspects of reversible inhibitors of monoamine oxidase\u2010A","display_name":"Some basic aspects of reversible inhibitors of monoamine oxidase\u2010A","publication_year":1990,"publication_date":"1990-09-01","ids":{"openalex":"https://openalex.org/W1997378488","doi":"https://doi.org/10.1111/j.1600-0447.1990.tb05317.x","mag":"1997378488","pmid":"https://pubmed.ncbi.nlm.nih.gov/2248079"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0447.1990.tb05317.x","doi":"https://doi.org/10.1111/j.1600-0447.1990.tb05317.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.1990.tb05317.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110437442","display_name":"M. Da Prada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"M. Da Prada","raw_affiliation_strings":["Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042605808","display_name":"Rolf Kettler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Kettler","raw_affiliation_strings":["Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111701042","display_name":"W.P. Burkard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"W. P. Burkard","raw_affiliation_strings":["Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113698219","display_name":"H.P. Lorez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"H. P. Lorez","raw_affiliation_strings":["Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000376319","display_name":"Willy E. Haefely","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"W. Haefely","raw_affiliation_strings":["Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110437442"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":5.2441,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.95946728,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"82","issue":"S360","first_page":"7","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/moclobemide","display_name":"moclobemide","score":0.972000002861023},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8809999823570251},{"id":"https://openalex.org/keywords/tyramine","display_name":"tyramine","score":0.8270000219345093},{"id":"https://openalex.org/keywords/monoamine-reuptake-inhibitors","display_name":"monoamine reuptake inhibitors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.6230000257492065},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/antihypoxic-effect","display_name":"antihypoxic effect","score":0.9409999847412109},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9879999756813049}],"concepts":[{"id":"https://openalex.org/C2780237459","wikidata":"https://www.wikidata.org/wiki/Q421934","display_name":"Moclobemide","level":4,"score":0.9803996682167053},{"id":"https://openalex.org/C2776077682","wikidata":"https://www.wikidata.org/wiki/Q165930","display_name":"Tyramine","level":2,"score":0.890403151512146},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.8111419677734375},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6305860280990601},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.624213695526123},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.5515685081481934},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4926331639289856},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.4876231253147125},{"id":"https://openalex.org/C114461151","wikidata":"https://www.wikidata.org/wiki/Q14888415","display_name":"Monoamine oxidase A","level":4,"score":0.4732956290245056},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.42269080877304077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3171290159225464},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.27445149421691895},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2304704189300537},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2213582694530487},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1836458146572113},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.17745602130889893},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.13759300112724304},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06040102243423462},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001143","descriptor_name":"Arousal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008995","descriptor_name":"Monoamine Oxidase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010624","descriptor_name":"Phenelzine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014191","descriptor_name":"Tranylcypromine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014439","descriptor_name":"Tyramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015102","descriptor_name":"3,4-Dihydroxyphenylacetic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020912","descriptor_name":"Moclobemide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0447.1990.tb05317.x","doi":"https://doi.org/10.1111/j.1600-0447.1990.tb05317.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.1990.tb05317.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},{"id":"pmid:2248079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2248079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta psychiatrica Scandinavica. Supplementum","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W41705150","https://openalex.org/W112085907","https://openalex.org/W1275227374","https://openalex.org/W1531843401","https://openalex.org/W1571697300","https://openalex.org/W1670429212","https://openalex.org/W1968257988","https://openalex.org/W1991414578","https://openalex.org/W1997609852","https://openalex.org/W2012851909","https://openalex.org/W2015825041","https://openalex.org/W2018270345","https://openalex.org/W2037354326","https://openalex.org/W2041287418","https://openalex.org/W2059727231","https://openalex.org/W2076036052","https://openalex.org/W2082521916","https://openalex.org/W2106707314","https://openalex.org/W2129679168","https://openalex.org/W2178409078","https://openalex.org/W2275421964","https://openalex.org/W2290846318","https://openalex.org/W2429230351","https://openalex.org/W2469938013","https://openalex.org/W2790524231","https://openalex.org/W4233203310","https://openalex.org/W4298071740","https://openalex.org/W4300163472","https://openalex.org/W4407049642"],"related_works":["https://openalex.org/W2096860914","https://openalex.org/W1819677300","https://openalex.org/W1981721430","https://openalex.org/W2414081879","https://openalex.org/W2336999759","https://openalex.org/W2418936755","https://openalex.org/W2331616323","https://openalex.org/W2401615228","https://openalex.org/W2077844594","https://openalex.org/W2093840662"],"abstract_inverted_index":{"A":[0,17],"novel":[1],"class":[2],"of":[3,13,33,40,47,55,67,81,88,91,113],"antidepressants":[4,105],"is":[5,21,26,45,76,106],"emerging":[6],"with":[7,35,74,103],"considerable":[8],"therapeutic":[9],"potential:":[10],"reversible":[11,31],"inhibitors":[12,69,73],"monoamine":[14,71],"oxidase":[15],"type":[16],"(RIMA).":[18],"Moclobemide":[19],"(Aurorix)":[20],"a":[22,27,36,51],"representative":[23],"RIMA.":[24],"It":[25,44],"fully":[28],"and":[29,49,70,93,98],"rapidly":[30],"inhibitor":[32],"MAO-A":[34],"correspondingly":[37],"intermediate":[38],"duration":[39],"action":[41],"in":[42,83],"vivo.":[43],"free":[46],"hepatotoxicity":[48],"produces":[50],"much":[52],"weaker":[53],"potentiation":[54],"the":[56,61,79],"tyramine":[57,75,89],"pressor":[58],"effect":[59],"than":[60],"classical":[62],"irreversible":[63],"MAO":[64,68],"inhibitors.":[65],"Interaction":[66],"reuptake":[72],"discussed":[77],"on":[78],"basis":[80],"experiments":[82],"conscious":[84],"rats.":[85],"The":[86],"issue":[87],"content":[90],"foods":[92],"beverages":[94],"has":[95],"been":[96],"reinvestigated":[97],"its":[99],"relevance":[100],"for":[101,118],"treatment":[102],"RIMA":[104],"discussed.":[107],"Recently":[108],"observed":[109],"antihypoxic":[110],"(neuroprotective)":[111],"effects":[112],"moclobemide":[114],"suggest":[115],"new":[116],"indications":[117],"this":[119],"compound.":[120]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}